Copyright
©The Author(s) 2022.
World J Clin Cases. Mar 26, 2022; 10(9): 2836-2843
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2836
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2836
Figure 2 Changes in pathological morphology and immunohistochemistry.
A: November 5, 2016, indicated adenocarcinoma, immunohistochemistry (IHC): CK-7+++, TTF-1+++; B: January 5, 2018, resistance to osimertinib, indicated small cell lung cancer, IHC: Syn+, TTF-1+; C: September 28, 2018, resistance to docetaxel + carboplatin + Anlotinib, suggested adenocarcinoma and small cell lung cancer, IHC: Syn+, NapsinA+. Magnification ×100.
- Citation: Hong E, Chen XE, Mao J, Zhou JJ, Chen L, Xu JY, Tao W. Sequential occurrence of T790M mutation and small cell lung cancer transformation in EGFR-positive lung adenocarcinoma: A case report. World J Clin Cases 2022; 10(9): 2836-2843
- URL: https://www.wjgnet.com/2307-8960/full/v10/i9/2836.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i9.2836